Durability of response to icotrokinra in the ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials
a potential new novel oral treatment for psoriasis.
Millette D
British Journal of DermatologyIn the feed 7 Aug 2026, issue 2026 Sep 18, added to PubMed 7 Aug 2026
Topics: PsoriasisJAK inhibitors & other targeted pills
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42563545 · DOI 10.1093/bjd/ljag323